LakePharma to present and showcase antibody discovery and protein engineering at PEGS Boston 2016

Added On: 2016-04-22

LakePharma's CEO Hua Tu will present at PEGS Boston on Tuesday April 26, 2016.

Presentation Details:

  • Overcoming Multiple Domain Challenges of Fc Fusions and Fab Fusion Bispecific Antibodies
    Speaker: Hua Tu, Chairman and CEO, LakePharma
    Date: Tuesday, April 26, 2016
    Time: 3:05 - 3:35 pm ET
    Stream: Bioconjugates
    Track: Fusion Protein Therapeutics: Engineering Enzymes
     

Dr. Tu will share data for the design, engineering, bioanalytical characterization and manufacturability assessment of Fc fusions and bispecific antibodies.

Company scientists will also present a poster detailing a tandem mass spectrometry approach to proteomic sequencing that enables the accurate determination of an antibody’s primary sequence when the source hybridoma is unavailable. In addition to revealing the full sequence of an important antibody, their approach enabled the engineering of the antibody to improve its production by CHO cells, as well as its performance as a purification reagent.

Details on Poster Sessions

  • Overcoming Multiple Domain Challenges of Fc Fusions and Fab Fusion Bispecific Antibodies
    Speaker: Hua Tu, Chairman and CEO, LakePharma
    Day: Tuesday April 26, 2016
    Time: 3:05 - 3:35 pm ET
    Stream: Bioconjugates
    Track: Fusion Protein Therapeutics: Engineering Enzymes
  • Poster A63: Proteomic Sequencing and Resurrection of a Monoclonal Antibody
    Authors: Natalie Castellana, Digital Proteomics; Kexin Huang and Hua Tu, LakePharma
    Presentation: April 25 and 26